Frontlight ResearchEarly access
Trial site
Los Angeles Hematology Oncology Medical Group
- 4running trials
- 3closed trials
The trials here
What the 7 trials at this site are about, from their registry records.
- Conditions
- Metastatic breast cancer4 trials
- Colorectal cancer1 trial
- Head and neck cancer1 trial
- Triple-negative breast cancer1 trial
- Phase
- Phase 35 trials
- Phase 22 trials
- Status
- Active, not recruiting4 trials
- Completed2 trials
- Terminated1 trial
- Lead sponsor
- G1 Therapeutics, Inc.1 trial
- Genentech, Inc.1 trial
- Gilead Sciences1 trial
- Hoffmann-La Roche1 trial
- NATCO Pharma Ltd.1 trial
- and 2 more
Running trials
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Closed trials
Recruiting
Terminated
Trilaciclib in Patients Receiving Sacituzumab Govitecan-hziy for Triple Negative Breast Cancer
Completed
Site data: ClinicalTrials.govUpdated 18 Nov 2026